Elucidating the multimodal anticancer mechanism of an organometallic terpyridine platinum(II) N-heterocyclic carbene complex against triple-negative breast cancer In Vitro and In Vivo

Treatment of triple-negative breast cancer (TNBC) has long been a medical challenge because of the lack of effective therapeutic targets. Targeting lipid, carbohydrate, and nucleotide metabolism pathways has recently been proven as a promising option in view of three heterogeneous metabolic-pathway-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhang, Jing-Jing (VerfasserIn) , Xu, Qi-Jie (VerfasserIn) , Schmidt, Claudia (VerfasserIn) , Abu El Maaty, Mohamed A. (VerfasserIn) , Song, Jinglin (VerfasserIn) , Yu, Chunqiu (VerfasserIn) , Zhou, Jun (VerfasserIn) , Han, Kang (VerfasserIn) , Sun, Hao (VerfasserIn) , Casini, Angela (VerfasserIn) , Ott, Ingo (VerfasserIn) , Wölfl, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 10 March 2023
In: Journal of medicinal chemistry
Year: 2023, Jahrgang: 66, Heft: 6, Pages: 3995-4008
ISSN:1520-4804
DOI:10.1021/acs.jmedchem.2c01925
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1021/acs.jmedchem.2c01925
Volltext
Verfasserangaben:Jing-Jing Zhang, Qi-Jie Xu, Claudia Schmidt, Mohamed A. Abu el Maaty, Jinglin Song, Chunqiu Yu, Jun Zhou, Kang Han, Hao Sun, Angela Casini, Ingo Ott, and Stefan Wölfl

MARC

LEADER 00000caa a2200000 c 4500
001 1843586630
003 DE-627
005 20230706211857.0
007 cr uuu---uuuuu
008 230426s2023 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.jmedchem.2c01925  |2 doi 
035 |a (DE-627)1843586630 
035 |a (DE-599)KXP1843586630 
035 |a (OCoLC)1389530529 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 30  |2 sdnb 
100 1 |a Zhang, Jing-Jing  |e VerfasserIn  |0 (DE-588)1210714434  |0 (DE-627)1698678193  |4 aut 
245 1 0 |a Elucidating the multimodal anticancer mechanism of an organometallic terpyridine platinum(II) N-heterocyclic carbene complex against triple-negative breast cancer In Vitro and In Vivo  |c Jing-Jing Zhang, Qi-Jie Xu, Claudia Schmidt, Mohamed A. Abu el Maaty, Jinglin Song, Chunqiu Yu, Jun Zhou, Kang Han, Hao Sun, Angela Casini, Ingo Ott, and Stefan Wölfl 
264 1 |c 10 March 2023 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 26.04.2023 
520 |a Treatment of triple-negative breast cancer (TNBC) has long been a medical challenge because of the lack of effective therapeutic targets. Targeting lipid, carbohydrate, and nucleotide metabolism pathways has recently been proven as a promising option in view of three heterogeneous metabolic-pathway-based TNBC subtypes. Here, we present a multimodal anticancer platinum(II) complex, named Pt(II)caffeine, with a novel mode of action involving simultaneous mitochondrial damage, inhibition of lipid, carbohydrate, and nucleotide metabolic pathways, and promotion of autophagy. All these biological processes eventually result in a strong suppression of TNBC MDA-MB-231 cell proliferation both in vitro and in vivo. The results indicate that Pt(II)caffeine, influencing cellular metabolism at multiple levels, is a metallodrug with increased potential to overcome the metabolic heterogeneity of TNBC. 
700 1 |a Xu, Qi-Jie  |e VerfasserIn  |4 aut 
700 1 |a Schmidt, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Abu El Maaty, Mohamed A.  |e VerfasserIn  |0 (DE-588)1125045477  |0 (DE-627)879376996  |0 (DE-576)483303607  |4 aut 
700 1 |a Song, Jinglin  |e VerfasserIn  |4 aut 
700 1 |a Yu, Chunqiu  |e VerfasserIn  |4 aut 
700 1 |a Zhou, Jun  |e VerfasserIn  |4 aut 
700 1 |a Han, Kang  |e VerfasserIn  |4 aut 
700 1 |a Sun, Hao  |e VerfasserIn  |4 aut 
700 1 |a Casini, Angela  |e VerfasserIn  |4 aut 
700 1 |a Ott, Ingo  |e VerfasserIn  |4 aut 
700 1 |a Wölfl, Stefan  |d 1959-  |e VerfasserIn  |0 (DE-588)121047458  |0 (DE-627)081052618  |0 (DE-576)260692360  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medicinal chemistry  |d Washington, DC : ACS, 1959  |g 66(2023), 6, Seite 3995-4008  |h Online-Ressource  |w (DE-627)302468846  |w (DE-600)1491411-6  |w (DE-576)090855132  |x 1520-4804  |7 nnas  |a Elucidating the multimodal anticancer mechanism of an organometallic terpyridine platinum(II) N-heterocyclic carbene complex against triple-negative breast cancer In Vitro and In Vivo 
773 1 8 |g volume:66  |g year:2023  |g number:6  |g pages:3995-4008  |g extent:14  |a Elucidating the multimodal anticancer mechanism of an organometallic terpyridine platinum(II) N-heterocyclic carbene complex against triple-negative breast cancer In Vitro and In Vivo 
856 4 0 |u https://doi.org/10.1021/acs.jmedchem.2c01925  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230426 
993 |a Article 
994 |a 2023 
998 |g 121047458  |a Wölfl, Stefan  |m 121047458:Wölfl, Stefan  |d 140000  |e 140000PW121047458  |k 0/140000/  |p 12  |y j 
998 |g 1125045477  |a Abu El Maaty, Mohamed A.  |m 1125045477:Abu El Maaty, Mohamed A.  |d 140000  |e 140000PA1125045477  |k 0/140000/  |p 4 
999 |a KXP-PPN1843586630  |e 4314464941 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 26.04.2023"],"recId":"1843586630","relHost":[{"origin":[{"dateIssuedDisp":"1959-","dateIssuedKey":"1959","publisher":"ACS ; ACS","publisherPlace":"Washington, DC ; Easton, Pa."}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"66(2023), 6, Seite 3995-4008","issue":"6","year":"2023","volume":"66","pages":"3995-4008","extent":"14"},"pubHistory":["1.1959 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"Journal of medicinal chemistry","title":"Journal of medicinal chemistry"}],"name":{"displayForm":["American Chemical Society"]},"language":["eng"],"disp":"Elucidating the multimodal anticancer mechanism of an organometallic terpyridine platinum(II) N-heterocyclic carbene complex against triple-negative breast cancer In Vitro and In VivoJournal of medicinal chemistry","recId":"302468846","id":{"zdb":["1491411-6"],"eki":["302468846"],"issn":["1520-4804"]},"note":["Gesehen am 02.10.2020"]}],"person":[{"given":"Jing-Jing","family":"Zhang","display":"Zhang, Jing-Jing","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Xu, Qi-Jie","family":"Xu","role":"aut","roleDisplay":"VerfasserIn","given":"Qi-Jie"},{"family":"Schmidt","display":"Schmidt, Claudia","roleDisplay":"VerfasserIn","role":"aut","given":"Claudia"},{"given":"Mohamed A.","role":"aut","roleDisplay":"VerfasserIn","display":"Abu El Maaty, Mohamed A.","family":"Abu El Maaty"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Song, Jinglin","family":"Song","given":"Jinglin"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Yu","display":"Yu, Chunqiu","given":"Chunqiu"},{"family":"Zhou","display":"Zhou, Jun","roleDisplay":"VerfasserIn","role":"aut","given":"Jun"},{"given":"Kang","role":"aut","roleDisplay":"VerfasserIn","family":"Han","display":"Han, Kang"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Sun, Hao","family":"Sun","given":"Hao"},{"given":"Angela","roleDisplay":"VerfasserIn","role":"aut","family":"Casini","display":"Casini, Angela"},{"given":"Ingo","roleDisplay":"VerfasserIn","role":"aut","family":"Ott","display":"Ott, Ingo"},{"given":"Stefan","display":"Wölfl, Stefan","family":"Wölfl","roleDisplay":"VerfasserIn","role":"aut"}],"id":{"doi":["10.1021/acs.jmedchem.2c01925"],"eki":["1843586630"]},"title":[{"title":"Elucidating the multimodal anticancer mechanism of an organometallic terpyridine platinum(II) N-heterocyclic carbene complex against triple-negative breast cancer In Vitro and In Vivo","title_sort":"Elucidating the multimodal anticancer mechanism of an organometallic terpyridine platinum(II) N-heterocyclic carbene complex against triple-negative breast cancer In Vitro and In Vivo"}],"name":{"displayForm":["Jing-Jing Zhang, Qi-Jie Xu, Claudia Schmidt, Mohamed A. Abu el Maaty, Jinglin Song, Chunqiu Yu, Jun Zhou, Kang Han, Hao Sun, Angela Casini, Ingo Ott, and Stefan Wölfl"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"14 S."}],"origin":[{"dateIssuedDisp":"10 March 2023","dateIssuedKey":"2023"}]} 
SRT |a ZHANGJINGJELUCIDATIN1020